GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The IBN SINA Pharmaceutical Industry PLC (DHA:IBNSINA) » Definitions » Accounts Payable

The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) Accounts Payable : BDT0.00 Mil (As of . 20)


View and export this data going back to . Start your Free Trial

What is The IBN SINA Pharmaceutical Industry Accounts Payable?

The IBN SINA Pharmaceutical Industry's Accounts Payable for the quarter that ended in . 20 was BDT0.00 Mil.


The IBN SINA Pharmaceutical Industry Accounts Payable Historical Data

The historical data trend for The IBN SINA Pharmaceutical Industry's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The IBN SINA Pharmaceutical Industry Accounts Payable Chart

The IBN SINA Pharmaceutical Industry Annual Data
Trend
Accounts Payable

The IBN SINA Pharmaceutical Industry Semi-Annual Data
Accounts Payable

The IBN SINA Pharmaceutical Industry Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


The IBN SINA Pharmaceutical Industry Accounts Payable Related Terms

Thank you for viewing the detailed overview of The IBN SINA Pharmaceutical Industry's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


The IBN SINA Pharmaceutical Industry Business Description

Traded in Other Exchanges
N/A
Address
Mirpur Road, Tanin Center, 3 Asad Gate, Mohammadpur, Dhaka, BGD, 1207
The IBN SINA Pharmaceutical Industry PLC is engaged in the production and marketing of pharmaceutical drugs and natural medicines in both the local and international market.

The IBN SINA Pharmaceutical Industry Headlines

No Headlines